Peptide

SS-31: How It Works, What It's Studied For & Safety

Quick answer

SS-31 is a mitochondrial-targeted peptide that binds cardiolipin on the inner mitochondrial membrane, studied for cellular-energy and cardiovascular research. Clinicians consider it for heart failure with preserved ejection fraction (HFpEF) - phase-3 trial program (PROGRESS). Not FDA-approved; dispensed by Wells Pharmacy Network only after a clinician evaluation.

Also known as: Elamipretide, MTP-131, Bendavia

How does SS-31 work?

SS-31 (elamipretide) is a small, cell-permeable peptide that selectively localizes to the inner mitochondrial membrane and binds cardiolipin. By stabilizing cristae structure and supporting electron-transport-chain efficiency, it is studied for restoring mitochondrial bioenergetics in stressed or aged tissues.

What is SS-31 studied for?

  • Heart failure with preserved ejection fraction (HFpEF) - phase-3 trial program (PROGRESS)
  • Primary mitochondrial myopathy
  • Age-related skeletal-muscle and cardiovascular endurance research

How is SS-31 taken?

Compounded as a subcutaneous injection in clinician-directed cycles. The branded clinical-trial preparation is administered as a daily subcutaneous injection.

Is SS-31 FDA-approved? Is it safe?

Not FDA-approved for the prevention, treatment, or cure of any condition. Used inside research-informed, clinician-directed protocols only. (Investigational under sponsor IND for specific mitochondrial indications.) Compounded prescription-only preparations are dispensed by Wells Pharmacy Network. Eligibility is decided by a licensed clinician based on intake and labs, not by checkout. Compounded products on this site are not FDA-approved and are not generic equivalents of any branded medication.

In the Regen Therapy catalog

The protocols below are dispensed by Wells Pharmacy Network and contain SS-31. Each one is prescribed only after a clinician evaluation.

What does the research say about SS-31?

Multiple sponsor-led clinical trials in cardiac and mitochondrial-disease populations; results have been mixed and an FDA approval has not yet been issued.

Considering SS-31 as part of a protocol?

Browse Regen Therapy's catalog or start a clinician evaluation. Every prescription is reviewed by a licensed clinician and dispensed by Wells Pharmacy Network.

Browse the catalog →